ITOS - Iteos Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ITOS is currently covered by 5 analysts with an average price target of $16.63. This is a potential upside of $6.48 (63.84%) from yesterday's end of day stock price of $10.15.

Iteos Therapeutics 's activity chart (see below) currently has 34 price targets and 30 ratings on display. The stock rating distribution of ITOS is 60% BUY and 40% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 14.6% with an average time for these price targets to be met of 98.6 days.

Highest price target for ITOS is $15, Lowest price target is $9, average price target is $12.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 28-May-2025. First documented stock forecast 18-Aug-2020.

Best performing analysts who are covering ITOS - Iteos Therapeutics :

David Nierengarten Daina Graybosch Swayampakula Ramakanth Christopher Neyor Brian Cheng

Currently out of the existing stock ratings of ITOS, 6 are a BUY (60%), 4 are a HOLD (40%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$12

$1.85 (18.23%)

$18

5 months 6 days ago
(28-May-2025)

2/7 (28.57%)

$1.94 (19.28%)

281

Hold

$9

$-1.15 (-11.33%)

$59

5 months 20 days ago
(14-May-2025)

1/3 (33.33%)

$1.4 (18.42%)

14

Hold

5 months 20 days ago
(14-May-2025)

1/9 (11.11%)

$13.26 (171.32%)

198

Hold

$15

5 months 21 days ago
(13-May-2025)

0/5 (0%)

$7.9 (111.27%)

Buy

$15

$4.85 (47.78%)

$24

7 months 28 days ago
(06-Mar-2025)

0/2 (0%)

$7.9 (111.27%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ITOS (Iteos Therapeutics ) average time for price targets to be met?

On average it took 98.6 days on average for the stock forecasts to be realized with a an average price target met ratio 14.6

Which analyst has the current highest performing score on ITOS (Iteos Therapeutics ) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the current lower performing score on ITOS (Iteos Therapeutics ) with a proven track record?

BRIAN CHENG

Which analyst has the most public recommendations on ITOS (Iteos Therapeutics )?

David Nierengarten works at WEDBUSH and has 8 price targets and 5 ratings on ITOS

Which analyst is the currently most bullish on ITOS (Iteos Therapeutics )?

Brian Cheng with highest potential upside - $4.85

Which analyst is the currently most reserved on ITOS (Iteos Therapeutics )?

Daina Graybosch with lowest potential downside - -$1.15

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?